Mark A. Schallenberger serves as Executive at Xtant Medical Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Mark A. Schallenberger has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 15, 2025 involved receiving (via award) 292,253 shares valued at $0.
Mark A. Schallenberger currently holds 670,866 shares of Xtant Medical Holdings, Inc. (XTNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Schallenberger has been a net neutral trader of XTNT stock. They have purchased $0 and sold $0 worth of shares.
Mark A. Schallenberger's most recent insider trade was on Nov 15, 2025, when they sold 292,253 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 15, 2023 | XTNT | $0 | Award | 116,144 | $N/A | Discretionary |
| Feb 15, 2023 | XTNT | $0 | Award | 89,000 | $N/A | Discretionary |